Pure Global

Variability in Microbial Response to Dietary Fiber - Trial NCT06023940

Access comprehensive clinical trial information for NCT06023940 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Missouri-Columbia and is currently Recruiting. The study focuses on Microbial Colonization. Target enrollment is 80 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06023940
Recruiting
dietary supplement
Trial Details
ClinicalTrials.gov โ€ข NCT06023940
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Variability in Microbial Response to Dietary Fiber

Study Focus

Microbial Colonization

High fiber

Interventional

dietary supplement

Sponsor & Location

University of Missouri-Columbia

Columbia, United States of America

Timeline & Enrollment

N/A

May 12, 2022

Apr 30, 2024

80 participants

Primary Outcome

Variability in microbial composition as measured by 'alpha diversity',Concentration of SCFA

Summary

The goal of this clinical trial is to understand varying in responses to different dietary
 patterns in healthy people who are getting a health screening colonoscopy.
 
 The main questions it aims to answer are:
 
 - What is the variability in the change of the microbes in the gut of (1) a provided diet
 that is high in fiber vs (2) a diet of the participant's choice.
 
 - What is the magnitude of fasting changes in glucose and lipids following the short-term,
 high-fiber feeding period and identify candidate predictive factors (short-chain fatty
 acids, BMI, sex, starting glucose level) for these changes
 
 Participants will be in one of two groups:
 
 1. High-fiber diet group: These participants will have a series of measurements that
 include: blood biochemistries, body composition measured via DEXA, anthropometrics,
 surveys and questionnaires, and collection of fecal samples.
 
 2. Normal diet group: These participants will eat a diet that is of their choosing (ad
 libitum) and will have a series of measurements that include: fecal samples, and
 questionnaires/surveys including food records.

ICD-10 Classifications

Bacterial infection of unspecified site
Other bacterial infections of unspecified site
Bacterial, viral and other infectious agents
Cholera
Other specified bacterial intestinal infections

Data Source

ClinicalTrials.gov

NCT06023940

Non-Device Trial